Your clinician may keep you on the starting dose longer to help manage them
doi: 10.1056/NEJMoa2307563
What did the FDA change about TRT cardiovascular safety in 2025
[Serum homocysteine, vitamin B12 and folic acid concentrations in patients with alcoholic liver cirrhosis]
Tirzepatide, a dual GIP and GLP-1 receptor agonist, extended this concept by demonstrating even greater weight reduction in adults with obesity or overweight
Injection-Based Administration Subcutaneous injections: All GLP-1 RAs are administered via subcutaneous injection Prefilled pens: Most common delivery system, allows for self-administration Auto-injectors: Simplify the process for patients with dexterity issues Multi-dose pens: Require dose dialing and needle attachment Dosing frequency: Daily: Liraglutide (Saxenda, Victoza), some formulations of exenatide (Byetta) Weekly: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide extended-release (Bydureon) Titration schedules: Most FDA-approved GLP-1 RAs require gradual dose escalation to minimize gastrointestinal side effects